Digital Therapeutics & Diagnostics

Digital Therapeutics (DTx) are evidence-based therapeutic interventions driven by software to prevent, manage, or treat a medical disorder or disease. In other words, DTx are patient-facing software applications that help patients treat, prevent, or manage a disease and that have a proven clinical benefit. For example, Digital Therapeutics can support patients in self-managing symptoms and thereby improve their quality of life and other clinical endpoints. DTx uses digital implements like mobile devices, apps, sensors, virtual reality, the Internet of Things, and other tools to spur behavioural changes in patients. DTx development can have a positive impact on providing well customised health services as their design is tailored to fit patient’s needs. Considered one of the most innovative areas within digital health, DTx ecosystem has experienced an accelerated period of progress over the past two years.

The process of identifying a disease, condition, or injury from its signs and symptoms. A health history, physical exam, and tests, such as blood tests, imaging tests, and biopsies, may be used to help make a diagnosis.

    Related Conference of Digital Therapeutics & Diagnostics

    March 27-28, 2024

    6th International Conference on Digital Health

    London, UK
    April 24-25, 2024

    35th European Heart and Heart Failure Congress

    Paris, France
    June 21-22, 2024

    52nd Global Nursing & Healthcare Conference

    Rome, Italy
    September 09-10, 2024

    3rd Global Summit on Physiology and Metabolism of Thyroid

    Paris, France
    September 18-19, 2024

    29th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    September 19-20, 2024

    20th Global Biomarkers and Clinical Research Summit

    Amsterdam, Netherlands
    September 24-25, 2024

    5th Global Summit on Public Health

    Paris, France

    Digital Therapeutics & Diagnostics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in